Vijaya Diagnostic

₹801.5 69.9 | 9.5%

WEBSITE BSE:543350 NSE : VIJAYA 10 May, 16:01

Market Cap ₹8217 Cr.

Stock P/E 69.0

P/B 12.5

Current Price ₹801.5

Book Value ₹ 64.1

Face Value 1

52W High ₹818

Dividend Yield 0.12%

52W Low ₹ 367.1

Edit Ratio

Vijaya Diagnostic Research see more...

Overview Inc. Year: 2002Industry: Hospital & Healthcare Services

Vijaya Diagnostic Centre Ltd offers diagnostic services for patients in India. It provides laboratory offerings, including medical biochemistry, haematology and immune-haematology, medical pathology, histopathology and cytopathology, microbiology, serology, cytogenetics, and molecular pathology; radiology and imaging services comprising magnetic resonance imaging, multi slice CT, CBCT (three-D dental), mammography, DEXA/bone densitometry, ultrasound/colour doppler, nuclear medicinal drug and PET/CT, and digital X-ray; and cardiology, neurology, and gastroenterology services. The employer additionally provides fitness checkups and home sample collection services. It has a network of 11 reference laboratories and 80 diagnostic centre across 13 cities and towns inside the states of Telangana and Andhra Pradesh, and in the National Capital Region and Kolkata. The corporation was founded in 1981 and is based totally in Hyderabad, India.

Vijaya Diagnostic Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Vijaya Diagnostic Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	111	116	104	121	113	121	121	139	133	155
Other Income	3	3	3	3	4	5	6	7	5	3
Total Income	114	119	107	124	117	126	127	146	138	158
Total Expenditure	63	68	64	72	69	72	73	81	80	92
Operating Profit	51	51	43	52	48	54	54	64	57	66
Interest	4	4	5	5	6	6	6	6	6	6
Depreciation	13	15	14	16	20	11	12	14	15	16
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	-2	0
Profit Before Tax	34	31	24	31	22	37	35	45	35	44
Provision for Tax	8	8	6	8	6	9	9	11	9	10
Profit After Tax	25	24	18	23	16	28	26	34	26	34
Adjustments	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Profit After Adjustments	25	24	17	23	16	27	26	33	26	33
Adjusted Earnings Per Share	2.5	2.3	1.7	2.3	1.6	2.7	2.6	3.3	2.5	3.3

Vijaya Diagnostic Profit & Loss

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	293	339	377	462	459	548
Other Income	10	15	12	13	14	21
Total Income	303	354	389	475	473	569
Total Expenditure	184	206	211	259	277	326
Operating Profit	118	148	178	217	196	241
Interest	14	15	15	16	21	24
Depreciation	40	49	50	53	62	57
Exceptional Income / Expenses	0	0	0	0	0	-2
Profit Before Tax	65	83	112	147	114	159
Provision for Tax	19	21	27	37	28	39
Profit After Tax	46	63	85	111	85	120
Adjustments	-0	0	-1	-1	-1	0
Profit After Adjustments	46	63	84	110	85	118
Adjusted Earnings Per Share	4.5	6.1	8.3	10.8	8.3	11.7

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-1%	11%	0%	0%
Operating Profit CAGR	-10%	10%	0%	0%
PAT CAGR	-23%	10%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	117%	NA%	NA%	NA%
ROE Average	17%	24%	24%	24%
ROCE Average	27%	35%	34%	34%

Vijaya Diagnostic Balance Sheet

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	207	275	359	468	545
Minority's Interest	-0	-0	0	1	2
Borrowings	32	22	3	0	0
Other Non-Current Liabilities	110	126	128	169	232
Total Current Liabilities	57	59	44	66	66
Total Liabilities	405	481	535	705	845
Fixed Assets	259	272	268	370	524
Other Non-Current Assets	9	23	28	64	46
Total Current Assets	137	186	239	270	276
Total Assets	405	481	535	705	845

Vijaya Diagnostic Cash Flow

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	16	10	56	7	11
Cash Flow from Operating Activities	91	106	130	158	165
Cash Flow from Investing Activities	-90	-31	-130	-123	-110
Cash Flow from Financing Activities	-7	-30	-49	-31	-42
Net Cash Inflow / Outflow	-6	46	-49	4	13
Closing Cash & Cash Equivalent	10	56	7	11	24

Vijaya Diagnostic Ratios

#	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	4.5	6.13	8.28	10.76	8.29
CEPS(Rs)	8.43	10.95	13.3	16.02	14.39
DPS(Rs)	0	0	0	1	1
Book NAV/Share(Rs)	20.11	26.92	35.13	45.73	53.18
Core EBITDA Margin(%)	36.95	39.14	44.05	44.05	39.64
EBIT Margin(%)	26.95	29.16	33.81	35.43	29.28
Pre Tax Margin(%)	22.32	24.62	29.76	31.88	24.72
PAT Margin (%)	15.81	18.45	22.6	23.93	18.55
Cash Profit Margin (%)	29.36	32.96	35.99	35.33	31.99
ROA(%)	11.42	14.11	16.76	17.85	11
ROE(%)	22.58	26.07	26.91	26.85	16.89
ROCE(%)	31.56	35.47	37.97	39.37	26.53
Receivable days	11.38	9.22	7.12	6.5	7.65
Inventory Days	2.72	2.67	2.62	2.73	2.51
Payable days	196.16	180.59	140.18	111.8	152.97
PER(x)	0	0	0	40.7	47.18
Price/Book(x)	0	0	0	9.57	7.36
Dividend Yield(%)	0	0	0	0.23	0.26
EV/Net Sales(x)	-0.01	-0.24	-0.49	9.24	8.44
EV/Core EBITDA(x)	-0.03	-0.55	-1.04	19.73	19.76
Net Sales Growth(%)	0	15.8	11.19	22.73	-0.68
EBIT Growth(%)	0	25.31	28.9	28.63	-17.93
PAT Growth(%)	0	35.09	36.19	30	-23.01
EPS Growth(%)	0	36.23	35.09	29.84	-22.92
Debt/Equity(x)	0.2	0.12	0.01	0	0
Current Ratio(x)	2.41	3.18	5.4	4.08	4.17
Quick Ratio(x)	2.37	3.13	5.34	4.02	4.14
Interest Cover(x)	5.83	6.42	8.35	9.96	6.42
Total Debt/Mcap(x)	0	0	0	0	0

Vijaya Diagnostic Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	54.78	54.78	55.04	55.01	55.01	55.01	54.98	54.9	54.87	54.06
FII	16.73	28.12	27.99	23.89	24.96	25.28	20.27	20.68	19.95	20.09
DII	24.6	13.08	12.81	15.77	14.22	13.9	19.03	18.64	19.82	20.8
Public	3.88	4.02	4.16	5.33	5.81	5.81	5.72	5.78	5.36	5.05
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	5.59	5.59	5.62	5.61	5.61	5.61	5.61	5.61	5.61	5.53
FII	1.71	2.87	2.86	2.44	2.55	2.58	2.07	2.11	2.04	2.06
DII	2.51	1.33	1.31	1.61	1.45	1.42	1.94	1.91	2.03	2.13
Public	0.4	0.41	0.42	0.54	0.59	0.59	0.58	0.59	0.55	0.52
Others	0	0	0	0	0	0	0	0	0	0
Total	10.2	10.2	10.2	10.21	10.21	10.21	10.21	10.23	10.23	10.23

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 24%
Company is almost debt free.

Cons

Debtor days have increased from 111.8 to 152.97days.
Stock is trading at 12.5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Vijaya Diagnostic News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Vijaya Diagnostic

Add Watchlist

Vijaya Diagnostic Research see more...

Overview Inc. Year: 2002Industry: Hospital & Healthcare Services

Vijaya Diagnostic Share Price

Alert Data

Quarterly Price

Peer Comparison

Vijaya Diagnostic Quarterly Results

Vijaya Diagnostic Profit & Loss

Growth Rates

Vijaya Diagnostic Balance Sheet

Vijaya Diagnostic Cash Flow

Vijaya Diagnostic Ratios

Vijaya Diagnostic Shareholding Pattern

Vijaya Diagnostic News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!